Answer
Imipramine hydrochloride is contraindicated during monoamine oxidase inhibitor treatment and for 3 weeks after stopping it, including concomitant treatment with selective, reversible MAO-A inhibitors such as moclobemide.
Sources for this answer
- Imipramine Hydrochloride 25mg/5ml Oral SolutionEssential Pharma Ltd · emc · SmPC §4.3 Contraindications · Version 4Document updated
Sources checked